You are currently viewing a new version of our website. To view the old version click .
Vaccines
  • Article
  • Open Access

24 April 2021

Nursing Home and Vaccination Consent: The Italian Perspective

,
,
,
,
and
1
Federico II University Ethics Committee, 80131 Naples, Italy
2
Law Department, Legal Medicine Section, Macerata University, 62100 Macerata, Italy
3
School of Law, Labour Law, Camerino University, 62032 Camerino, Italy
4
School of Law, Legal Medicine, Camerino University, 62032 Camerino, Italy
This article belongs to the Special Issue Safety Concerns, Sources of Liability, Compensation Strategies and the Right to Be Informed: Ethical and Legal Issues of COVID-19 Vaccination

Abstract

Since the beginning of the Covid-19 pandemic, many countries have begun vaccination campaigns, with different methods and timelines, with the goal of vaccinating over 75% of the population and thus achieving herd immunity. Initially it was necessary to identity the categories of citizens who should be the first to receive the vaccines, on the basis of scientific evidence. On the basis of this information, elderly residents in nursing homes and the staff who care for them should be the highest priority subjects for vaccination. In this context, obtaining informed consent to Covid-19 vaccination presents a considerable challenge, as the advanced age and frequent comorbidities of a significant number of the residents may mean that they are incapable of expressing consent themselves. The legislation of various Western nations substantially agrees on the general principle that those capable of judgement must be asked for their consent for healthcare services, and that even those with psychological weaknesses that limit their full ability to decide must be involved in these decision-making processes. The article can help systematize the processes to be implemented to protect the health of individuals as members of a close and fragile community.

1. Introduction

Since the beginning of the Covid-19 pandemic, worldwide efforts to contain its effects have focused on research [1] to develop vaccinations, often through synergy between the public and private sectors. This objective has been achieved in record time [2,3] while respecting all the required phases for authorization to put the vaccinations on the market, under the aegis of the various drug agencies (EMA European Medicine Agency, FDA Food and Drugs Administration, etc.) [4,5,6,7,8].
Many countries have begun vaccination campaigns, with different methods and timelines, with the goal of vaccinating over 75% of the population and thus achieving herd immunity [9].
In this context, most Western nations have prioritized the order in which various categories of citizens should be vaccinated [10].
Initially, the number of vaccine doses was insufficient to vaccinate the entire population, and thus it was necessary to identity the categories of citizens who should be the first to receive them 10, on the basis of scientific evidence. Health was identified as the first right to be safeguarded and thus the first criterion for identifying the highest priority categories.
Very strong scientific evidence indicated that the risk of death from Covid-19 increased exponentially with the increase in age [11,12,13].
In addition, epidemiological studies pointed to the fact that residents of nursing homes were the category worst hit by Covid-19 infection, first, because these community settings inherently present higher risk of exposure to the infection, and second, because residents already have comorbidities and thus are already at higher clinical risk for grave illness and death [14,15,16].
On the basis of this information, elderly residents in nursing homes and the staff who care for them should be the highest priority subjects for vaccination. In fact, staff in residential nursing homes have been shown to have higher infection rates than workers who provide assistance in private homes [14,15,16]. Thus, the twofold goal of vaccinating residential nursing home staff is to avoid having asymptomatic but contagious infected staff members spread the disease among residents, and also to prevent negative repercussions on healthcare in nursing homes caused by staff absences due to illness.

2. The State of the Art on Europe

The legislation on vaccination campaigns developed by many nations is substantially uniform in identifying the residents and workers of nursing homes as very high priority subjects to be vaccinated, on the basis of scientific evidence. The following is the position of some European states, which together are representative of all the possible situations that exist in the remaining member states.
The United Kingdom’s 25 September 2020 independent report “JVCI Advice on Priority Groups for Covid-19 Vaccination”, updated numerous times [17], most recently on 5 January 2021 [18] identified the following priorities for the administration of the vaccine in England, Wales, and Northern Ireland [19]
those aged 80 and up;
those who live or work in nursing homes;
healthcare and social workers at high risk;
and, for Scotland, it dictated vaccination for “residents in a nursing home for the elderly and their carers”.
In Italy, the Strategic Plan for “Anti-SARS-CoV-2/COVID-19 Vaccination [20]” established priority vaccination for “Residents and staff of residential nursing homes for the elderly” with the logistics to be organized by the Health Ministry [21].
In Spain, the National Healthcare System initially formed a working group that wrote its “Estrategia de vacunación frente a COVID19 en España [22]”, establishing the priority groups for vaccination, at the top of which was “Residents and healthcare and social workers in nursing homes for the elderly and/or disabled. If necessary, priority goes to vaccinations for the most vulnerable residences (the greatest number of prisoners, poorest ability to adopt prevention and control measures and/or residences that have not had Covid-19 cases)”.
In France, in the initial phase of the Covid19 pandemic, the National Authority on Healthcare [23] prioritized two populations for vaccination on the basis of the parame ters of vulnerability (age and/or comorbidities) and risk of greater exposure to the virus:
(1)
Residents of nursing home structures and residents in long-term care facilities (EHPAD, USLD, etc.);
(2)
Professionals who work in institutions for the elderly (mainly EHPAD and USLD), also at greater risk of severe forms of infectious disease or death (those over 65 and/or with comorbidities).
The same priority was substantially established in other nations of the European Union and in most parts of the United States [24].
Thus, there is a unanimous opinion of residents and staff in nursing homes for the elderly as those who should be the first to be vaccinated, given that the residents belong to the oldest group and frequently have comorbidities that increase their vulnerability to Covid 19 infection [25,26].

4. Vaccination of Nursing Home Workers

In Italy, there is no law for making vaccine against Covid-19 mandatory and, as a consequence, there is no legal obligation for workers. Despite the lack of a general rule, we can call into question whether there is an obligation by reading the special provisions on the employment relationship. The interpretations are varied and differentiated, however they are concentrated in two main orientations: on the one hand, there is room for making vaccinations compulsory in the company by looking at articles 2087 Civil Code as well as 20 and 279 of Legislative Decree No. 81/2008, because the employer has a legal obligation to ensure health and safety at work; on the other hand, according to Article 32, paragraph 2, of the Italian Constitution, only a law can force a person to undergo health treatment: this perspective is enforced by articles 5 and 8, of Law No. 300/1970 (the so-called Charter of Workers’ rights) that clashes with the first option.

5. The Role of Compulsory Vaccination

A central issue is whether or not vaccination is compulsory for healthcare staff in assisted-living facilities. There is a very high probability (rebuttable presumption) for healthcare workers that they may come into contact with coronavirus, aside from their hospital ward, as well as for non-healthcare staff working in the hospitals for technical support, cleaning or aides, etc. The assisted healthcare residence staff are exposed to a high risk of occupational illness. During the pandemic phase, this means that the specific work carried out by a nurse is in itself a factor that increases the risk of Covid-19 infection. For this reason, the role of compulsory vaccination cannot be underestimated, except in cases of refusal justified by medical reasons or dangerous situations endangering worker’s health and safety (Art. 44 of the Legislative Decree no. 81/2008). The lack of vaccination, however, would make the worker’s service not useful for employers, especially in health and social care contexts where employees are in close contact with patients. This is a circumstance of supervening impossibility of performing conditions (or partial impossibility ratione tempuras); as a consequence, by applying the articles 1256, paragraph 2, and 1464 of the Civil Code we should balance the employer’s interest to layoff against the employee’s interest in maintaining employment. Following the refusal to be vaccinated by the employee the employer may refuse the worker performance and, consequently, the suspension of the employment relationship without pay. Moreover, the lack of a specific provision to ensure a general obligation to vaccinate is not a sufficient argument to exclude any liability on the employee side in the context of health services such as assisted healthcare residence. With regard to this specific context, the most cautious approach is to recommend vaccinations or, more incisively, to impose an additional burden to the worker in this particular sector, this means introducing another obligation in order to achieve a specific result: maintaining the employment relationship and, at the same time, reducing other risks out of the employment relationship related to social contact with other workers or other third parties (patients and their families).
To support the latter approach, we can refer to article 1 of Law No. 24/2017, which indirectly ensures every patient the right to safe care. The same provision imposes an obligation of providing healthcare treatments safely and avoiding any foreseeable related risk to public and private health facilities as well as to all practitioners of health professions. Article 1, paragraph 2, Law No. 24/2017 states that “the safety of care is also achieved through the set of all activities aimed at the prevention and management of risk” and that (paragraph 3) “the risk prevention activities implemented by public private health care facilities, is required to contribute all employees, including professionals affiliated”.

6. Recent Case Law and New Legislation

The vaccine against Covid-19 gives us complex problems with regard to the employment relationship, especially looking at some workplaces such as the assisted-living facilities. The dilemma between obligations based on individual consent and obligations based on reciprocity arises again. Although the tendency is to believe that acquiring consent is enough to avoid legal complaints, it is difficult to make ethical sense of community life if anyone does not recognize the power of solidarity (collective interest).
Recently, the Court of Belluno has ruled by order of 19 March 2021 on the appeal brought by some nursing home workers who have refused the COVID-19 vaccine despite being at their disposal and were put on paid leave by the employer. The judge considered legitimate leave and rejected the appeal arguing that now the vaccine is able to protect the physical integrity of individuals to whom it is administered, preventing the spread of disease and given the high risk in which residents of such facilities incur, the employer has an obligation to protect employees under Article 2087 of the Civil Code and therefore it is legitimate to change a job or remove the employee who will return once vaccinated. However, it is questionable what decision to take once the vacation period is over. Precisely on this issue, the decree of 1 April 2021, provided in art. 4, that all workers in the health sector are obliged to undergo anti-Covid vaccination, which is an essential requirement for the exercise of the profession and for the performance of work services rendered by the obliged parties. The refusal of the worker determines the suspension, without pay, from the right to perform services or tasks at risk of spreading Covid-19 infection until the fulfillment of the vaccination obligation or, failing that, until the completion of the national vaccination plan and in any case not later than 31 December 2021.

7. Conclusions

In conclusion, the beginning of the Covid-19 pandemic found the world community unprepared, and efforts to deal with it have been varied and uncoordinated, both by individual nations and by international organizations such as the United Nations, World Health Assembly, European Union, United Kingdom, United States. After the WHO declaration of the pandemic nature of the Covid-19 infection in January 2020, each state has applied very different measures to contain the contagion.
Unfortunately, even when it was possible to foresee critical situations and to organize appropriate systems in good time, on all levels there was lack of diligence that only deepened crises and produced risks for the health of individuals and the community. In Italy, which was the European country first affected by the infection, it was the one in which the incidence of mortality was highest. The lack of attention to strict containment measures relating to contacts with the outside and to control the staff and their late application in Italy have caused such a rapid spread of the disease in nursing homes which, affecting particularly fragile subjects, have led to unacceptable mortality rates. This negative experience led, after the approval of the anti-Covid-19 vaccines, to the production in Italy of some measures that specifically concerned the vaccination of subjects residing in nursing homes and the staff that work in who became part of the first categories subject to vaccination. This made it possible, during the second phase of the pandemic, to limit the contagion of these structures and significantly reduce mortality. Vaccines have a high social value because in addition to protecting the vaccinated person, they reduce the risk of contagion to the rest of the population. Vaccination is therefore a continuous balance between the individual and collective dimension of health in the spirit of mutual solidarity between the individual and the community. It is hoped that the proposals made in this article related to the Italian country can help systematize the processes to be implemented to protect the health of individuals as members of a close and fragile community.

Author Contributions

Conceptualization: N.C., P.F., M.C.; methodology: M.C., P.F.; formal analysis: R.S., N.C.; writing-original draft preparation: N.C., F.S., M.M.F.; writing-review and editing: M.C., R.S., M.M.F.; supervision: M.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of University of Macerata (protocol code 012/2021 of 12 February 2021).

Data Availability Statement

The study did not report any data of patients.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Research Ethics during the COVID-19 Pandemics. Considerations on Observational and in Particular Epidemiologic Studies; ISS Bioethics COVID-19 Working Group n. 47/2020: Roma, Italy, 2020. [Google Scholar]
  2. Sharma, O.; Sultan, A.A.; Ding, H.; Triggle, C.R. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19. Front. Immunol. 2020, 11, 585354. [Google Scholar] [CrossRef]
  3. Graham, B.S. Rapid COVID-19 vaccine development. Science 2020, 368, 945–946. [Google Scholar] [CrossRef]
  4. Knoll, M.D.; Wonodi, C. Oxford-AstraZeneca COVID-19 vaccine efficacy. Lancet 2021, 397, 72–74. [Google Scholar] [CrossRef]
  5. Haynes, B.F.; Corey, L.; Fernandes, P.; Gilbert, P.B.; Hotez, P.J.; Rao, S.; Santos, M.R.; Schuitemaker, H.; Watson, M.; Arvin, A. Prospects for a safe COVID-19 vaccine. Sci. Transl. Med. 2020, 12, 568. [Google Scholar] [CrossRef] [PubMed]
  6. Oliver, S.E.; Gargano, J.W.; Marin, M.; Wallace, M.; Curran, K.G.; Chamberland, M.; McClung, N.; Campos-Outcalt, D.; Morgan, R.L.; Mbaeyi, S.; et al. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine—United States, December 2020. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 1922–1924. [Google Scholar] [CrossRef] [PubMed]
  7. COVID-19 Vaccines: Development, Evaluation, Approval and Monitoring. Available online: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/covid-19-vaccines-development-evaluation-approval-monitoring (accessed on 15 January 2021).
  8. Position of EUREC on the Responsibility of Research Ethics Committees during the COVID-19 Pandemic. Available online: http://www.eurecnet.org/news (accessed on 18 January 2021).
  9. Omer, S.B.; Yildirim, I.; Forman, H.P. Herd Immunity and Implications for SARS-CoV-2 Control. JAMA 2020, 324, 2095–2096. [Google Scholar] [CrossRef]
  10. European Centre for Disease Prevention and Control. COVID-19 Vaccination and Prioritisation Strategies in the EU/EEA. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-vaccination-and-prioritisation-strategies.pdf (accessed on 20 January 2021).
  11. Williamson, E.J.; Walker, A.J.; Bhaskaran, K.; Bacon, S.; Bates, C.; Morton, C.E.; Curtis, H.J.; Mehrkar, A.; Evans, D.; Inglesby, P.; et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020, 584, 430–436. [Google Scholar] [CrossRef]
  12. Clift, A.K.; Coupland, C.A.C.; Keogh, R.H.; Diaz-Ordaz, K.; Williamson, E.; Harrison, E.M.; Hayward, A.; Hemingway, H.; Horby, P.; Mehta, N.; et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: National derivation and validation cohort study. BMJ 2020, 371, 3731. [Google Scholar] [CrossRef]
  13. NHS Who’s at Higher Risk from Coronavirus. Available online: https://www.nhs.uk/conditions/coronavirus-covid-19/people-at-higher-risk/whos-at-higher-risk-from-coronavirus/ (accessed on 10 February 2021).
  14. Ladhani, S.N.; Chow, J.Y.; Janarthanan, R.; Fok, J.; Crawley-Boevey, E.; Vusirikala, A.; Fernandez, E.; Perez, M.S.; Tang, S.; Dun-Campbell, K.; et al. Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020. EClinicalMedicine 2020, 26, 100533. [Google Scholar] [CrossRef]
  15. Ladhani, S.N.; Chow, J.Y.; Janarthanan, R.; Fok, J.; Crawley-Boevey, E.; Vusirikala, A.; Fernandez, E.; Perez, M.S.; Tang, S.; Dun-Campbell, K.; et al. London Care Home Investigation Team. Increased risk of SARS-CoV-2 infection in staff working across different care homes: Enhanced CoVID-19 outbreak investigations in London care Homes. J. Infect. 2020, 81, 621–624. [Google Scholar] [CrossRef]
  16. Graham, N.S.N.; Junghans, C.; Downes, R.; Sendall, C.; Lai, H.; McKirdy, A.; Elliott, P.; Howard, R.; Wingfield, D.; Priestman, M.; et al. SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes. J. Infect. 2020, 81, 411–419. [Google Scholar] [CrossRef] [PubMed]
  17. Joint Committee on Vaccination and Immunisation: Advice on Priority Groups for COVID-19 Vaccination. Available online: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/950113/jcvi-advice-on-priority-groups-for-covid-19-vaccination-30-dec-2020-revised.pdf (accessed on 16 January 2021).
  18. Statement from the Joint Committee on Vaccination and Immunisation (JCVI) about Increasing the Short-Term Impact of the COVID-19 Vaccination Programme. Available online: https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement (accessed on 16 January 2021).
  19. Coronavirus (COVID-19): Guidance and Support—GOV.UK. Available online: https://www.gov.uk/coronavirus (accessed on 16 January 2021).
  20. The Strategic Plan for “Anti-SARS-CoV-2/COVID-19 Vaccination”. Available online: https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2021&codLeg=78657&parte=1&serie=null (accessed on 16 January 2021).
  21. Recommendations for the Organization of the Vaccination Campaign against SARS-CoV-2/COVID-19 and Vaccination Procedure. Available online: https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2020&codLeg=77981&parte=1&serie=null (accessed on 16 January 2021).
  22. Estrategia de Vacunación Frente a COVID19 en España. Available online: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/COVID-19_EstrategiaVacunacion.pdf (accessed on 16 January 2021).
  23. Sars-Cov-2 Vaccination Strategy—Preliminary Recommendations on the Strategy for Prioritizing the Populations to be Vaccinated. Available online: https://www.has-sante.fr/jcms/p_3221338/fr/strategie-de-vaccination-contre-le-sars-cov-2-recommandations-preliminaires-sur-la-strategie-de-priorisation-des-populations-a-vacciner (accessed on 15 January 2021).
  24. The COVID-19 “Vaccination Line”: An Update on State Prioritization Plan. 2021. Available online: https://www.kff.org/coronavirus-covid-19/issue-brief/the-covid-19-vaccination-line-an-update-on-state-prioritization-plans/# (accessed on 16 January 2021).
  25. World Health Organisation Europe. Health Workers at Risk, Older Adults and Residents of Long-Term Care Facilities to be Prioritized for COVID-19 Vaccination; WHO Euro: Copenhagen, Denmark, 2020; Available online: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid19/news/news/2020/11/health-workers-at-risk,-older-adults-and-residents-of-long-term-care-facilities-to-beprioritized-for-covid-19-vaccination (accessed on 16 January 2021).
  26. European Centre for Disease Prevention and Control. Key Aspects Regarding the Introduction and Prioritisation of COVID-19 Vaccination in the EU/EEA and the UK. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/Key-aspects-regarding-introduction-and-prioritisation-of-COVID-19-vaccination.pdf (accessed on 25 January 2021).
  27. Carbajal, E. Nursing Homes Struggle to Obtain Resident Vaccine Consent. Available online: https://www.beckershospitalreview.com/post-acute/nursing-homes-struggle-to-obtain-resident-vaccine-consent.html (accessed on 16 January 2021).
  28. The Convention was Opened for Signature on 4 April 1997 in Oviedo, Spain and is thus Otherwise Known as the Oviedo Convention. It Entered into Force on 1 December 1999 as the First Multilateral Binding Instrument Entirely Devoted to Biolaw. Thirty-Five Countries have Signed the Convention, However only 29 of These have also Ratified the Convention. Oviedo Convention. Available online: https://rm.coe.int/168007d003 (accessed on 11 January 2021).
  29. Art. 32 Constitution of the Italian Republic, Art. 35-37 Medical Deontological Code, FNOMCeO, Roma. 2014.
  30. Law 22 December 2017, no. 219. Norms Regulating Informed Consent and Advance Treatment Directives. Available online: http://www.gazzettaufficiale.it/eli/id/2018/1/16/18G00006/sg (accessed on 16 January 2021).
  31. The Mental Capacity Act 2005 GOV.UK. Available online: https://www.hft.org.uk/resources-and-guidance/disability-rights-and-legal/mental-capacity-act/?gclid=CjwKCAjwg4-EBhBwEiwAzYAlsr8DPitQxZkGgLGKm6Dxt3hrFbmqupHQTPF78n-LCn53qzXw_LZXeBoCmr8QAvD_BwE (accessed on 16 January 2021).
  32. Code de la Santé Publique. Available online: https://www.legifrance.gouv.fr/codes/section_lc/LEGITEXT000006072665/LEGISCTA000006125345/2016-02-04/-LEGISCTA000006125345 (accessed on 12 January 2021).
  33. Ratgeber für Patientenrechte. Available online: https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/5_Publikationen/Gesundheit/Broschueren/Ratgeber_fuer_Patientenrechte_bf.pdf (accessed on 12 January 2021).
  34. Ley 41/2002, de 14 de Noviembre, Básica Reguladora de la Autonomía del Paciente y de Derechos y Obligaciones en Materia de Información y Documentación Clínica. Available online: https://www.boe.es/buscar/pdf/2002/BOE-A-2002-22188-consolidado.pdf (accessed on 16 January 2021).
  35. Szilagyi, P.G.; Thomas, K.; Shah, M.D.; Vizueta, N.; Cui, Y.; Vangala, S.; Kapteyn, A. National Trends in the US Public’s Likelihood of Getting a COVID-19 Vaccine-April 1 to December 8, 2020. JAMA 2020, 325, 396–398. [Google Scholar] [CrossRef]
  36. Volpp, K.G.; Loewenstein, G.; Buttenheim, A.M. Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program. JAMA 2021, 325, 125–126. [Google Scholar] [CrossRef]
  37. Wang, J.; Jing, R.; Lai, X.; Zhang, H.; Lyu, Y.; Knoll, M.D.; Fang, H. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines 2020, 8, 482. [Google Scholar] [CrossRef] [PubMed]
  38. CNB, I vaccini e COVID-19: Aspetti Etici per la Ricerca, il Costo e la Distribuzione. Available online: http://bioetica.governo.it/media/4082/p140_2020_vaccini-e-covid19_it.pdf (accessed on 16 January 2021).
  39. Art. 5 Decree Law n.1 of 5 January 2021. Available online: https://www.gazzettaufficiale.it/eli/id/2021/01/05/21G00001/sg (accessed on 16 January 2021).
  40. Cembrani, F.; Asioli, F.; Bianchetti, A.; Ferrannini, L.; Mossello, E.; Scapati, F.; Trabucchi, M. La pianificazione condivisa della cura e l’autodeterminazione della persona anziana affetta da patologie psicogeriatriche. Psicogeriatria 2018, 12, 1–33. [Google Scholar]
  41. Ingravallo, F.; Cerquetti, I.; Vignatelli, L.; Albertini, S.; Bolcato, M.; Camerlingo, M.; Corbi, G.; De Leo, D.; De Nicolò, A.; De Stefano, F.; et al. Medico-legal assessment of personal damage in older people: Report from a multidisciplinary Consensus Conference. Int. J. Legal Med. 2020, 134, 2319–2334. [Google Scholar] [CrossRef] [PubMed]
  42. Ryan, T.; Amen, K.M.; McKeown, J. The advance care planning experiences of people with dementia, family caregivers and professionals: A synthesis of the qualitative literature. Ann. Palliat. Med. 2017, 6, 380–389. [Google Scholar] [CrossRef] [PubMed]
  43. Montanari Vergallo, G.; Cisale, G.Y.; di Luca, N.M.; Marinelli, E.; Zaami, S. Informed consent to research trials on Alzheimer’s disease: How to foster research without infringing upon the patient’s right to self-determination. Pharmacol. Res. 2018, 132, 69–71. [Google Scholar] [CrossRef]
  44. Kim, S.Y. The ethics of informed consent in Alzheimer disease research. Nat. Rev. Neurol. 2011, 7, 410–414. [Google Scholar] [CrossRef]
  45. Beattie, B.L. Consent in Alzheimer’s disease research: Risk/benefit factors. Can. J. Neurol. Sci. 2007, 34, 27–31. [Google Scholar] [CrossRef]
  46. Kim, S.Y.; Uhlmann, R.A.; Appelbaum, P.S.; Knopman, D.S.; Kim, H.M.; Damschroder, L.; Beattie, E.; Struble, L.; De Vries, R. Deliberative assessment of surrogate consent in dementia research. Alzheimers Dement. 2010, 6, 342–350. [Google Scholar] [CrossRef]
  47. Gostin, L.O.; Salmon, D.; Larson, H. Mandating COVID-19 Vaccines. JAMA 2021, 325, 532–533. [Google Scholar] [CrossRef]
  48. Alzheimer’s Society was Formed in 1979 and Actually Operates in England, Wales and Northern Ireland with the Purpose of Helping People with the Different Types of Dementia. Consent to Coronavirus (COVID-19) Vaccination. Available online: https://www.alzheimers.org.uk/get-support/coronavirus/consent-vaccine-covid-19-vaccination (accessed on 12 February 2021).
  49. Appelbaum, P.S.; Grisso, T. The MacArthur Treatment Competence Study. I: Mental illness and competence to consent to treatment. Law Hum. Behav. 1995, 19, 105–126. [Google Scholar] [CrossRef]
  50. Craig Barstow, M.D.; Brian Shahan, M.D.; ROBERTS, M. Evaluating Medical Decision-Making Capacity in Practice. Am. Fam. Physician 2018, 98, 40–46. [Google Scholar]
  51. Buchanan, A.E.; Brock, D.W. Deciding for Others: The Ethics of Surrogate Decision Making; Cambridge University Press: Cambridge, UK, 1989. [Google Scholar]
  52. Tunzi, M. Can the patient decide? Evaluating patient capacity in practice. Am. Fam. Physician 2001, 64, 299–306. [Google Scholar] [PubMed]
  53. Baumrucker, S.J.; York, P.; Stolick, M.; VandeKieft, G.; Hutchinson, L.; Adkins, R.W.; Rashid, S.; Winiger, D. Autonomy and Withdrawal of Treatment in a Patient With Depression. Am. J. Hosp. Palliat. Care 2017, 35, 908–914. [Google Scholar] [CrossRef] [PubMed]
  54. Álvaro, L.C. Competency: General principles and applicability in dementia. Neurología 2012, 27, 290–300. [Google Scholar] [CrossRef] [PubMed]
  55. Carroll, D.W. Assessment of capacity for medical decision making. J. Gerontol. Nurs. 2010, 36, 47–52. [Google Scholar] [CrossRef]
  56. D’Errico, S.; Turillazzi, E.; Zanon, M.; Viola, R.V.; Frati, P.; Fineschi, V. The Model of “Informed Refusal” for Vaccination: How to Fight against Anti-Vaccinationist Misinformation without Disregarding the Principle of Self-Determination. Vaccines 2021, 9, 110. [Google Scholar] [CrossRef]
  57. Jeste, D.V.; Eglit, G.M.L.; Palmer, B.W.; Martinis, J.G.; Blanck, P.; Saks, E.R. Supported Decision Making in Serious Mental Illness. Psychiatry 2018, 81, 28–40. [Google Scholar] [CrossRef]
  58. Davidson, G.; Kelly, B.; Macdonald, G.; Rizzo, M.; Lombard, L.; Abogunrin, O.; Clift- Matthews, V.; Martin, A. Supported decision making: A review of the international literature. Int. J. Law Psychiatry 2015, 38, 61–67. [Google Scholar] [CrossRef] [PubMed]
  59. Blanck, P.; Martinis, J.G. “The right to make choices”: The national resource center for supported decision-making. Inclusion 2015, 3, 24–33. [Google Scholar] [CrossRef]
  60. Jameson, J.M.; Riesen, T.; Polychronis, S.; Trader, B.; Mizner, S.; Martinis, J.; Hoyle, D. Guardianship and the Potential of Supported Decision Making With Individuals With Disabilities. Res. Pract. Pers. Sev. Disabil. 2015, 40, 36–51. [Google Scholar] [CrossRef]
  61. Assemblea delle Nazioni Unite. Convention on the Rights of Persons with Disabilities (CRPD) 2006. Available online: https://www.un.org/development/desa/disabilities/convention-on-the-rights-of-persons-with-disabilities.htmlFulltext (accessed on 16 January 2021).
  62. Nandini, D.; Jerome, B.; Gerold, S. Moving towards substituted or supported decision-making? Article 12 of the Convention on the Rights of Persons with Disabilities. Alter 2011, 5, 249–264. [Google Scholar]
  63. Arstein-Kerslake, A.; Watson, J.; Browning, M.; Martinis, J.; Blanck, P. Future direction in supported decision making. Disabil. Stud. Q. 2017, 37, 5070. [Google Scholar] [CrossRef]
  64. Art. 5 Decree Law n.44 of April 1, 2021. Available online: https://www.gazzettaufficiale.it/eli/id/2021/04/01/21G00056/sg (accessed on 16 January 2021).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.